Oncomed Pharmaceuticals Inc's ability to collect accounts receivable sequentially worsen to 48.49, pointing to a challenging and on top of that deteriorating business climate for the Major Pharmaceutical Preparations industry. Oncomed Pharmaceuticals Inc's Accounts Receivable average collection period in the Dec 31 2018 quarter, has increased to 8 days, from 2 days, in the Sep 30 2018 quarter.

If we take a look into Healthcare sector 22 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 295, from overall ranking in the third quarter 2018 at 1761.

What is Receivable Turnover Ratio?
What is Oncomed Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

OMED Receivables Turnover Ratio	(Dec 31 2018) IV. Quarter	(Sep 30 2018) III. Quarter	(Jun 30 2018) II. Quarter	(Mar 31 2018) I. Quarter	(Dec 31 2017) IV. Quarter
Y / Y Receivable Change	647.16 %	19.54 %	-94.47 %	-84.38 %	-83.9 %
Y / Y Revenue Change	-42.11 %	282.26 %	10.9 %	26.33 %	231.89 %
Receivable Turnover Ratio (TTM)	48.49	184.62	144.39	53.04	34.72
OMED's Total Ranking	# 295	# 1761	# 292	# 2507	# 2158
Accounts Receivable average collection period days	8	2	3	7	11
Seq. Receivable Change	627.4 %	278.18 %	-57.36 %	-36.3 %	16.38 %
Seq. Revenue Change	-38.78 %	184.1 %	-12.47 %	-61.97 %	304.23 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 16
Healthcare Sector	# 23
Overall Market	# 295

Receivable Turnover Ratio Statistics
High	Average	Low
778.04	99.91	1.25
(Mar 31 2014)		(Mar 31 2016)

OMED Company Profile • Back to OMED Efficiency Comparisons • Compare OMED Receivables Turnover Ratio to its Competitors

Financial Statements
Oncomed Pharmaceuticals Inc's Accounts Receivable	$ 3 Millions	Visit OMED's Balance sheet
Oncomed Pharmaceuticals Inc's Sales TTM	$ 46 Millions	Visit OMED's Income Statement
Sources of OMED's Revenues		Visit OMED's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
OMED's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
OMED's Growth Rates	OMED's Roa	OMED's Inventory Turnover Ratio	OMED's Dividend Comparisons
OMED's Profitability Ratios	OMED's Roi	OMED's Asset Turnover Ratio	OMED's Dividend Growth
OMED's Valuation Ratios	OMED's Roe	OMED's Financial Strength Ratios	OMED's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2018, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2018	Receivable at quarter ending Dec 31 2018
Geovax Labs Inc	39.72	$ 1.406 Millions	$ 0.035 Millions
Axim Biotechnologies Inc	39.12	$ 0.196 Millions	$ 0.005 Millions
Nektar Therapeutics	37.86	$ 1,193.323 Millions	$ 31.518 Millions
Ardelyx inc	36.98	$ 2.607 Millions	$ 0.071 Millions
Sonida Senior Living Inc	36.52	$ 460.018 Millions	$ 12.597 Millions
Galapagos Nv	36.47	$ 323.496 Millions	$ 8.869 Millions
Brookdale Senior Living Inc	35.72	$ 4,531.426 Millions	$ 126.868 Millions
Ainos Inc	34.64	$ 0.078 Millions	$ 0.002 Millions
Miragen Therapeutics Inc	33.75	$ 8.386 Millions	$ 0.249 Millions
Innovation1 Biotech Inc	33.49	$ 0.013 Millions	$ 0.000 Millions
Cardiff Lexington Corporation	32.04	$ 2.374 Millions	$ 0.074 Millions
Premier Biomedical Inc	31.47	$ 0.040 Millions	$ 0.001 Millions
Viskase Holdings inc	28.53	$ 6.918 Millions	$ 0.243 Millions
Guardion Health Sciences Inc	28.45	$ 0.942 Millions	$ 0.033 Millions
Portola Pharmaceuticals inc	27.44	$ 40.130 Millions	$ 1.462 Millions
Dariohealth Corp	27.13	$ 7.394 Millions	$ 0.273 Millions
Theravance Biopharma inc	26.68	$ 60.370 Millions	$ 2.263 Millions
Momenta Pharmaceuticals inc	26.59	$ 75.589 Millions	$ 2.843 Millions
Immunogen inc	26.42	$ 55.261 Millions	$ 2.092 Millions
Vbi Vaccines Inc	25.86	$ 3.355 Millions	$ 0.130 Millions
Harrow Inc	25.01	$ 41.372 Millions	$ 1.654 Millions
Acura Pharmaceuticals inc	24.48	$ 0.410 Millions	$ 0.017 Millions
Paratek Pharmaceuticals Inc	24.16	$ 17.117 Millions	$ 0.709 Millions
Regenxbio Inc	23.04	$ 218.505 Millions	$ 9.482 Millions
Fortress Biotech Inc	22.90	$ 191.943 Millions	$ 8.384 Millions
Organogenesis Holdings Inc	22.71	$ 193.449 Millions	$ 8.519 Millions
Ernexa Therapeutics Inc	21.99	$ 23.319 Millions	$ 1.060 Millions
Chimerix Inc	21.67	$ 7.082 Millions	$ 0.327 Millions
Journey Medical Corp	21.30	$ 42.339 Millions	$ 1.988 Millions
Acadia Healthcare Company Inc	21.16	$ 6,973.025 Millions	$ 329.538 Millions

Date modified: 2026-06-22T14:32:11+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.